Sindhu P Cherian from Philadelphia, PA, age 40

Methods For Diagnosis Of Myelodysplastic Syndromes (Mds)
view source
US Patent:

8377649, Feb 19, 2013
Filed:

Feb 1, 2011
Appl. No.:

13/019167
Inventors:

Jonni Moore - Moorestown NJ, US
Sindhu Cherian - Seattle WA, US
Adam Bagg - Gulph Mills PA, US
Assignee:

The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:

A61K 49/00
G01N 33/574
US Classification:

435 723, 435 72, 435 724, 4352872, 435973, 424 92, 436 10, 436 63, 436 64, 436164, 436172, 436811, 436813, 422 73, 422 8208, 422 8209
Abstract:

The present invention relates to methods and kits for diagnosing, ascertaining the clinical course of myelodysplastic syndrome (MDS) and ascertaining response to a therapy regimen of myelodysplastic syndrome. Specifically the invention provides methods and kits useful in the diagnosis and determination of clinical parameters associated with MDS based on surface markers unique to MDS.

Method For Diagnosis Of Myelodysplastic Syndromes (Mds)
view source
US Patent:

20080026406, Jan 31, 2008
Filed:

Nov 7, 2005
Appl. No.:

11/667406
Inventors:

Jonni Moore - Moorestown NJ, US
Sindhu Cherian - Seattle WA, US
Adam Bagg - Gulph Mills PA, US
International Classification:

G01N 33/567
US Classification:

435007200
Abstract:

The present invention provides a method of diagnosing a mylodysplastic syndrome, a method of ascertaining the clinical course of a myelodysplastic syndrome or a method of ascertaining response to a therapy regimen in a subject diagnosed with a myelodysplastic syndrome, and kits for effecting the same.

Methods For Diagnosis Of Myelodysplastic Syndromes (Mds)
view source
US Patent:

20130196346, Aug 1, 2013
Filed:

Jan 11, 2013
Appl. No.:

13/739250
Inventors:

The Trustees of the University of Pennsylvania - Philadelphia PA, US
Sindhu Cherian - Seattle WA, US
Adam Bagg - Gulph Mills PA, US
Assignee:

The Trustees of the University of Pennsylvania - Philadelphia PA
International Classification:

G01N 33/50
US Classification:

435 721, 435 29
Abstract:

The present invention relates to methods and kits for diagnosing, ascertaining the clinical course of myelodysplastic syndrome (MDS) and ascertaining response to a therapy regimen of myelodysplastic syndrome. Specifically the invention provides methods and kits useful in the diagnosis and determination of clinical parameters associated with MDS based on surface markers unique to MDS.